We provide diagnostic solutions which determine the source of disease & contamination to improve patient health & ensure consumer safety #PioneeringDiagnostics" title="" class="btn" data-container="body" data-html="true" data-id="59708" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="bioMérieux"> 15,306 1,684 270 1,115 343,253
Sectors
Location
100 All. Louis Raymond, 69280 Marcy-l'Étoile, France
Marcy-l'Étoile
France
SIREN
673620399Engaged entities
437Added in Motherbase
18 Sep 2019, 4:49 p.m.Pioneering Diagnostics
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis
Pioneering Diagnostics
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
bioMérieux | Pioneering Diagnostics
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
IUT Lyon 1 Higher Education, edtech | Other 24 Jan 2025 | | ||
Pasteur Foundation - UK healthtech | Other 30 Nov 2024 | | ||
Nucleate France UniCA it services | Other 9 Jan 2025 | | ||
CARL Berger-Levrault Software Development, it services | Other 13 Dec 2024 | | ||
l'Essentiel Lyon it services | Other 22 Dec 2024 | | ||
IEEPI - Institut Européen Entreprise et Propriété Intellectuelle Higher Education, edtech | Other 17 Dec 2024 | | ||
Centre de Congrès de Lyon Events Services | Other 27 Dec 2024 | | ||
AVEF : Association Vétérinaire Équine Française pettech | Other 28 Nov 2024 | | ||
Les Cités d'Or Civic and Social Organizations, edtech | Other 12 Dec 2024 | | ||
Relations Médicales Events Services | Other 5 Dec 2024 | |